Literature DB >> 24513048

1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase.

John M Keith1, Natalie Hawryluk2, Richard L Apodaca2, Allison Chambers2, Joan M Pierce2, Mark Seierstad2, James A Palmer2, Michael Webb2, Mark J Karbarz2, Brian P Scott2, Sandy J Wilson2, Lin Luo2, Michelle L Wennerholm2, Leon Chang2, Michele Rizzolio2, Sandra R Chaplan2, J Guy Breitenbucher2.   

Abstract

A series of 1-aryl-2-(((6-aryl)pyrimidin-4-yl)amino)ethanols have been found to be competitive inhibitors of fatty acid amide hydrolase (FAAH). One member of this class, JNJ-40413269, was found to have excellent pharmacokinetic properties, demonstrated robust central target engagement, and was efficacious in a rat model of neuropathic pain.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Analgesia; Crystal structure; Endo-cannabinoids; Enzymes; Fatty acid amide hydrolase (FAAH)

Mesh:

Substances:

Year:  2014        PMID: 24513048     DOI: 10.1016/j.bmcl.2014.01.064

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.

Authors:  John M Keith; William M Jones; Mark Tichenor; Jing Liu; Mark Seierstad; James A Palmer; Michael Webb; Mark Karbarz; Brian P Scott; Sandy J Wilson; Lin Luo; Michelle L Wennerholm; Leon Chang; Michele Rizzolio; Raymond Rynberg; Sandra R Chaplan; J Guy Breitenbucher
Journal:  ACS Med Chem Lett       Date:  2015-11-02       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.